Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Division of Research, Kaiser Permanente Northern California, Oakland, California, USA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Kidney Int. 2018 Apr;93(4):968-976. doi: 10.1016/j.kint.2017.10.017. Epub 2018 Jan 15.
Renal recovery after dialysis-requiring acute kidney injury (AKI-D) is an important clinical and patient-centered outcome. Here we examined whether the pre-admission proteinuria level independently influences risk for non-recovery after AKI-D in a community-based population. All adult members of Kaiser Permanente Northern California who experienced AKI-D between January 1, 2009 and September 30, 2015 were included. Pre-admission proteinuria levels were determined by dipstick up to four years before the AKI-D hospitalization and the outcome was renal recovery (survival and dialysis-independence four weeks and more) at 90 days after initiation of renal replacement therapy. We used multivariable logistic regression to adjust for baseline estimated glomerular filtration rate (eGFR), age, sex, ethnicity, short-term predicted risk of death, comorbidities, and medication use. Among 5,347 adults with AKI-D, the mean age was 66 years, 59% were men, and 50% were white. Compared with negative/trace proteinuria, the adjusted odds ratios for non-recovery (continued dialysis-dependence or death) were 1.47 (95% confidence interval 1.19-1.82) for 1+ proteinuria and 1.92 (1.54-2.38) for 2+ or more proteinuria. Among survivors, the crude probability of recovery ranged from 83% for negative/trace proteinuria with baseline eGFR over 60 mL/min/1.73m to 25% for 2+ or more proteinuria with eGFR 15-29 mL/min/1.73m. Thus, the pre-AKI-D level of proteinuria is a graded, independent risk factor for non-recovery and helps to improve short-term risk stratification for patients with AKI-D.
透析依赖型急性肾损伤(AKI-D)后的肾脏恢复是一个重要的临床和以患者为中心的结局。在这里,我们研究了在基于社区的人群中,入院前蛋白尿水平是否独立影响 AKI-D 后的恢复风险。所有在 2009 年 1 月 1 日至 2015 年 9 月 30 日期间经历 AKI-D 的 Kaiser Permanente 北加利福尼亚州的成年成员均被纳入研究。入院前蛋白尿水平通过尿试纸在 AKI-D 住院前四年内确定,结局为肾脏恢复(开始肾脏替代治疗后 90 天的存活和透析独立)。我们使用多变量逻辑回归来调整基线估计肾小球滤过率(eGFR)、年龄、性别、种族、短期死亡预测风险、合并症和药物使用。在 5347 例 AKI-D 成人中,平均年龄为 66 岁,59%为男性,50%为白人。与阴性/微量蛋白尿相比,1+蛋白尿的调整后无恢复(持续依赖透析或死亡)比值比为 1.47(95%置信区间 1.19-1.82),2+或更多蛋白尿的调整后比值比为 1.92(1.54-2.38)。在幸存者中,从基线 eGFR 超过 60 mL/min/1.73m 的阴性/微量蛋白尿的恢复率为 83%,到 eGFR 为 15-29 mL/min/1.73m 的 2+或更多蛋白尿的恢复率为 25%,恢复率的范围各不相同。因此,入院前蛋白尿水平是一个分级的、独立的非恢复风险因素,有助于改善 AKI-D 患者的短期风险分层。